Blog

Idorsia Forms Research Collaboration With Roche On Cancer Immunotherapy – Nasdaq

Idorsia Forms Research Collaboration With Roche On Cancer Immunotherapy
Nasdaq
(RTTNews.com) – Idorsia Ltd said that it reached a research collaboration that provides Roche with an exclusive option right to develop and market first-in-class compounds for a promising new approach in the field of cancer immunotherapy. The companies

and more »

2017-12-20 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.